708 related articles for article (PubMed ID: 10235695)
1. Mirtazapine: a review of its use in major depression.
Holm KJ; Markham A
Drugs; 1999 Apr; 57(4):607-31. PubMed ID: 10235695
[TBL] [Abstract][Full Text] [Related]
2. A risk-benefit assessment of mirtazapine in the treatment of depression.
Kasper S; Praschak-Rieder N; Tauscher J; Wolf R
Drug Saf; 1997 Oct; 17(4):251-64. PubMed ID: 9352961
[TBL] [Abstract][Full Text] [Related]
3. Review of the results from clinical studies on the efficacy, safety and tolerability of mirtazapine for the treatment of patients with major depression.
Fawcett J; Barkin RL
J Affect Disord; 1998 Dec; 51(3):267-85. PubMed ID: 10333982
[TBL] [Abstract][Full Text] [Related]
4. Mirtazapine : A Review of its Pharmacology and Therapeutic Potential in the Management of Major Depression.
Davis R; Wilde MI
CNS Drugs; 1996 May; 5(5):389-402. PubMed ID: 26071050
[TBL] [Abstract][Full Text] [Related]
5. Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.
Foster RH; Goa KL
CNS Drugs; 1997 Aug; 8(2):163-88. PubMed ID: 23338224
[TBL] [Abstract][Full Text] [Related]
6. A review of the pharmacological and clinical profile of mirtazapine.
Anttila SA; Leinonen EV
CNS Drug Rev; 2001; 7(3):249-64. PubMed ID: 11607047
[TBL] [Abstract][Full Text] [Related]
7. Safety reporting and adverse-event profile of mirtazapine described in randomized controlled trials in comparison with other classes of antidepressants in the acute-phase treatment of adults with depression: systematic review and meta-analysis.
Watanabe N; Omori IM; Nakagawa A; Cipriani A; Barbui C; McGuire H; Churchill R; Furukawa TA;
CNS Drugs; 2010 Jan; 24(1):35-53. PubMed ID: 20030418
[TBL] [Abstract][Full Text] [Related]
8. Mirtazapine. A pharmacoeconomic review of its use in depression.
Holm KJ; Jarvis B; Foster RH
Pharmacoeconomics; 2000 May; 17(5):515-34. PubMed ID: 10977391
[TBL] [Abstract][Full Text] [Related]
9. Tianeptine: a review of its use in depressive disorders.
Wagstaff AJ; Ormrod D; Spencer CM
CNS Drugs; 2001; 15(3):231-59. PubMed ID: 11463130
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and tolerability of mirtazapine versus citalopram: a double-blind, randomized study in patients with major depressive disorder. Nordic Antidepressant Study Group.
Leinonen E; Skarstein J; Behnke K; Agren H; Helsdingen JT
Int Clin Psychopharmacol; 1999 Nov; 14(6):329-37. PubMed ID: 10565799
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of antidepressants in the treatment of severe depression: the place of mirtazapine.
Kasper S
J Clin Psychopharmacol; 1997 Apr; 17 Suppl 1():19S-28S. PubMed ID: 9090574
[TBL] [Abstract][Full Text] [Related]
12. Remission with mirtazapine and selective serotonin reuptake inhibitors: a meta-analysis of individual patient data from 15 controlled trials of acute phase treatment of major depression.
Thase ME; Nierenberg AA; Vrijland P; van Oers HJ; Schutte AJ; Simmons JH
Int Clin Psychopharmacol; 2010 Jul; 25(4):189-98. PubMed ID: 20531012
[TBL] [Abstract][Full Text] [Related]
13. [Mirtazapine versus other antidepressive agents for depression].
Knud Larsen J
Ugeskr Laeger; 2012 Nov; 174(46):2864-6. PubMed ID: 23153468
[TBL] [Abstract][Full Text] [Related]
14. Mirtazapine versus selective serotonin reuptake inhibitors.
Thompson C
J Clin Psychiatry; 1999; 60 Suppl 17():18-22; discussion 46-8. PubMed ID: 10446737
[TBL] [Abstract][Full Text] [Related]
15. Double-blind, randomized comparison of mirtazapine and paroxetine in elderly depressed patients.
Schatzberg AF; Kremer C; Rodrigues HE; Murphy GM;
Am J Geriatr Psychiatry; 2002; 10(5):541-50. PubMed ID: 12213688
[TBL] [Abstract][Full Text] [Related]
16. Clinical efficacy of mirtazapine: a review of meta-analyses of pooled data.
Kasper S
Int Clin Psychopharmacol; 1995 Dec; 10 Suppl 4():25-35. PubMed ID: 8930007
[TBL] [Abstract][Full Text] [Related]
17. Mirtazapine: a review of its use in major depression and other psychiatric disorders.
Croom KF; Perry CM; Plosker GL
CNS Drugs; 2009; 23(5):427-52. PubMed ID: 19453203
[TBL] [Abstract][Full Text] [Related]
18. Mirtazapine: an antidepressant with noradrenergic and specific serotonergic effects.
Stimmel GL; Dopheide JA; Stahl SM
Pharmacotherapy; 1997; 17(1):10-21. PubMed ID: 9017762
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of mirtazapine in clinically relevant subgroups of depressed patients.
Nutt DJ
Depress Anxiety; 1998; 7 Suppl 1():7-10. PubMed ID: 9597345
[TBL] [Abstract][Full Text] [Related]
20. Mirtazapine: clinical advantages in the treatment of depression.
Burrows GD; Kremer CM
J Clin Psychopharmacol; 1997 Apr; 17 Suppl 1():34S-39S. PubMed ID: 9090576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]